XML 22 R12.htm IDEA: XBRL DOCUMENT v3.21.2

Investment Securities Available for Sale, at Fair Value

9 Months Ended

Sep. 30, 2021

Investments, Debt and Equity Securities [Abstract]

Investment Securities Available for Sale, at Fair Value

Investment Securities Available for Sale, at Fair Value

The Company accounts for certain of its investment securities available for sale using the fair value election pursuant to ASC 825, Financial Instruments ("ASC 825"), where changes in fair value are recorded in unrealized gains (losses), net on the Company's condensed consolidated statements of operations. The Company also has investment securities available for sale where the fair value option has not been elected, which we refer to as CECL Securities. CECL Securities are reported at fair value with unrealized gains and losses recorded in other comprehensive income (loss) on the Company's condensed consolidated statements of comprehensive income. The Company's investment securities available for sale consisted of the following as of September 30, 2021 and December 31, 2020, respectively (dollar amounts in thousands):

			September 30, 2021																								December 31, 2020
			Amortized Cost						Unrealized												Fair Value						Amortized Cost						Unrealized												Fair Value
									Gains						Losses																		Gains						Losses
Fair Value Option
Agency RMBS			$	129,198					$	—					$	(3,609)					$	125,589					$	138,541					$	854					$	—					$	139,395
Non-Agency RMBS (1)			108,579						1,168						(3,064)						106,683						100,465						170						(10,786)						89,849
CMBS			32,600						1,139						—						33,739						139,019						5,685						(3,731)						140,973
ABS			24,343						17,142						—						41,485						34,139						9,086						—						43,225
Total investment securities available for sale - fair value option			294,720						19,449						(6,673)						307,496						412,164						15,795						(14,517)						413,442
CECL Securities
Non-Agency RMBS (2)			115,686						2,482						(75)						118,093						266,855						4,336						(5,374)						265,817
CMBS			22,869						—						(365)						22,504						43,435						2,032						—						45,467
Total investment securities available for sale - CECL Securities			138,555						2,482						(440)						140,597						310,290						6,368						(5,374)						311,284
Total			$	433,275					$	21,931					$	(7,113)					$	448,093					$	722,454					$	22,163					$	(19,891)					$	724,726

(1)Includes non-Agency RMBS held in a securitization trust with a total fair value of $37.6 million as of December 31, 2020. During the nine months ended September 30, 2021, the Company exercised its right to an optional redemption of its non-Agency RMBS re-securitization, returning the non-Agency RMBS held by the re-securitization trust to the Company (see Note 7).

(2)Includes non-Agency RMBS held in a securitization trust with a total fair value of $71.5 million as of December 31, 2020. During the nine months ended September 30, 2021, the Company exercised its right to an optional redemption of its non-Agency RMBS re-securitization, returning the non-Agency RMBS held by the re-securitization trust to the Company (see Note 7).

Accrued interest receivable for all investment securities available for sale in the amount of $1.0 million and $2.4 million as of September 30, 2021 and December 31, 2020, respectively, is included in other assets on the Company's condensed consolidated balance sheets.

Realized Gain and Loss Activity

The following tables summarize our investment securities sold during the three months ended September 30, 2021 and 2020, respectively (dollar amounts in thousands):

			Three Months Ended September 30, 2021
			Sales Proceeds						Realized Gains						Realized Losses						Net Realized Gains (Losses)
Non-Agency RMBS			$	43,579					$	4,841					$	—					$	4,841
CMBS			89,481						5,496						(452)						5,044
Total			$	133,060					$	10,337					$	(452)					$	9,885

			Three Months Ended September 30, 2020
			Sales Proceeds						Realized Gains						Realized Losses						Net Realized Gains (Losses)
Non-Agency RMBS			$	259,493					$	141					$	(8,860)					$	(8,719)
CMBS			110,680						6,849						(705)						6,144
Total			$	370,173					$	6,990					$	(9,565)					$	(2,575)

The following tables summarize our investment securities sold during the nine months ended September 30, 2021 and 2020, respectively (dollar amounts in thousands):

			Nine Months Ended September 30, 2021
			Sales Proceeds						Realized Gains						Realized Losses						Net Realized Gains (Losses)
Non-Agency RMBS (1)			$	115,662					$	4,853					$	(833)					$	4,020
CMBS			132,796						11,083						(452)						10,631
Total			$	248,458					$	15,936					$	(1,285)					$	14,651

			Nine Months Ended September 30, 2020
			Sales Proceeds						Realized Gains						Realized Losses						Net Realized Gains (Losses)
Agency RMBS:
Agency ARMs			$	49,892					$	44					$	(4,157)					$	(4,113)
Agency Fixed-Rate (1)			943,074						5,358						(11,697)						(6,339)
Total Agency RMBS			992,966						5,402						(15,854)						(10,452)
Agency CMBS (2)			145,411						5,666						(209)						5,457
Total Agency			1,138,377						11,068						(16,063)						(4,995)
Non-Agency RMBS			428,251						435						(34,681)						(34,246)
CMBS			248,741						8,176						(30,289)						(22,113)
Total			$	1,815,369					$	19,679					$	(81,033)					$	(61,354)

(1)Includes Agency RMBS securities issued by Consolidated SLST (see Note 7).

(2)Includes Agency CMBS securities transferred from the Consolidated K-Series (see Note 7).

The Company recognized a write-down of fair value option non-Agency RMBS IOs for a realized loss of $4.8 million for the three and nine months ended September 30, 2021.

Weighted Average Life

Actual maturities of our investment securities available for sale are generally shorter than stated contractual maturities (with contractual maturities up to 38 years), as they are affected by periodic payments and prepayments of principal on the underlying mortgages. As of September 30, 2021 and December 31, 2020, based on management’s estimates, the weighted average life of the Company’s investment securities available for sale portfolio was approximately 5.4 years and 5.6 years, respectively.

The following table sets forth the weighted average lives of our investment securities available for sale as of September 30, 2021 and December 31, 2020, respectively (dollar amounts in thousands):

Weighted Average Life			September 30, 2021						December 31, 2020
0 to 5 years			$	223,991					$	332,934
Over 5 to 10 years			206,360						320,361
10+ years			17,742						71,431
Total			$	448,093					$	724,726

Unrealized Losses in Other Comprehensive Income

The Company evaluated its CECL Securities that were in an unrealized loss position as of September 30, 2021 and December 31, 2020, respectively, and determined that no allowance for credit losses was necessary. The Company did not recognize credit losses for its CECL Securities through earnings for the three and nine months ended September 30, 2021 and 2020.

The following table presents the Company's CECL Securities in an unrealized loss position with no credit losses reported, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position as of September 30, 2021 and December 31, 2020, respectively (dollar amounts in thousands):

September 30, 2021			Less than 12 months												Greater than 12 months												Total
			Carrying Value						Gross Unrealized Losses						Carrying Value						Gross Unrealized Losses						Carrying Value						Gross Unrealized Losses
Non-Agency RMBS			$	35,532					$	(22)					$	36,739					$	(53)					$	72,271					$	(75)
CMBS			22,504						(365)						—						—						22,504						(365)
Total			$	58,036					$	(387)					$	36,739					$	(53)					$	94,775					$	(440)

December 31, 2020			Less than 12 months												Greater than 12 months												Total
			Carrying Value						Gross Unrealized Losses						Carrying Value						Gross Unrealized Losses						Carrying Value						Gross Unrealized Losses
Non-Agency RMBS			$	159,841					$	(4,526)					$	8,234					$	(848)					$	168,075					$	(5,374)
Total			$	159,841					$	(4,526)					$	8,234					$	(848)					$	168,075					$	(5,374)

At September 30, 2021, the Company did not intend to sell any of its investment securities available for sale that were in an unrealized loss position, and it was “more likely than not” that the Company would not be required to sell these securities before recovery of their amortized cost basis, which may be at their maturity.

Gross unrealized losses in other comprehensive income on the Company's non-Agency RMBS and CMBS were $0.4 million at September 30, 2021. Credit risk associated with non-Agency RMBS and CMBS is regularly assessed as new information regarding the underlying collateral becomes available and based on updated estimates of cash flows generated by the underlying collateral. In performing its assessment, the Company considers past and expected future performance of the underlying collateral, including timing of expected future cash flows, prepayment rates, default rates, loss severities, delinquency rates, current levels of subordination, volatility of the security's fair value, temporary declines in liquidity for the asset class and interest rate changes since purchase. Based upon the most recent evaluation, the Company does not believe that these unrealized losses are credit related but are rather a reflection of current market yields and/or marketplace bid-ask spreads.

X

- References

No definition available.

+ Details

Name:	us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for investments in certain debt and equity securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-URI http://asc.fasb.org/subtopic&trid=2209399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 320
-URI http://asc.fasb.org/subtopic&trid=2324412

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-URI http://asc.fasb.org/topic&trid=2196928

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 940
-SubTopic 320
-URI http://asc.fasb.org/subtopic&trid=2176304

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher SEC
-Name Regulation S-K (SK)
-Number 229
-Section 1403
-Paragraph (b)

+ Details

Name:	us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration